While many conversations surrounding ketamine in the last few years have mainly revolved around its illicit use as a party drug, trials have been ongoing around the world looking into the ...

These data support the immune-mediated anti-cancer activity of the proposed dual MOA of amezalpat,” said Sam Whiting, M.D., Ph.D., chief medical officer and head of R&D at Tempest, "and are consistent ...

A chemical cousin of ketamine, esketamine works by targeting a neurotransmitter called glutamate, which may restore brain connections that help relieve depression symptoms. Professor Ian Hickie ...

For example, Johnson & Johnson has already launched a new drug that claims to fix ‘errant’ brain structures for tackling depression: esketamine (trade name Spravato). The company claims ...

Spravato, which contains esketamine, will be added to the Pharmaceutical Benefits Scheme (PBS) from May 1, becoming the first new type of depression medication to be funded by the federal ...

MoA Clear Passage 2050 Fund earns a High Process Pillar rating. The most important driver of the rating is its parent firm's superior long-term risk-adjusted performance, as shown by the firm's ...

The esketamine nasal spray – sold as Spravato by Johnson & Johnson – is the first new class of depression drug subsidised by the Pharmaceutical Benefits Scheme in more than 30 years.

MoA Clear Passage 2065 Fund earns a High Process Pillar rating. The primary contributor to the rating is its parent firm's excellent long-term risk-adjusted performance, as shown by the firm's ...

Not long ago, pistol red dots weren’t much more than a novelty or niche competition tool. Today they are the standard. Red dot reflex sights help us shoot pistols faster and more accurately, and we ...

Yesterday, the drugmaker added to the evidence behind Spravato – an intranasal formulation of esketamine – with the release of top-line data from a head-to-head study with a long-acting ...

Postpartum depression risk increases with psychological abuse, even without physical or sexual violence. Intimate partner violence affects 4% to 8% of pregnant women in the U.S. and is associated ...